⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27618852 | 0.98 | — | — | |
| SCHEMBL30707297 | 0.68 | GABRP (0.31) | — | |
| SCHEMBL4955614 | 0.67 | TP53 (0.41) | — | |
| SCHEMBL28809329 | 0.62 | — | — | |
| SCHEMBL14300771 | 0.62 | — | — | |
| SCHEMBL3385199 | 0.62 | — | — | |
| SCHEMBL604100 | 0.59 | — | — | |
| SCHEMBL27695906 | 0.59 | — | — | |
| SCHEMBL4609316 | 0.59 | — | — | |
| SCHEMBL27571380 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117164522-A | Aminomide oxidation impurity and preparation method thereof | 安徽峆一药业股份有限公司 | 2023-12-05 | — | — | CN | claimed |
| US-7332354-B2 | Compounds for chemiluminescense procedures | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2008-02-19 | — | — | US | claimed |
| EP-4583977-A1 | HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS | Chiesi Farmaceutici S.p.A. (IT) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024125464-A1 | TETRAHYDROISOQUINOLIN-ONE DERIVATIVES, PREPARATION METHODS AND MEDICINAL USES THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) | 2024-06-20 | — | — | WO | disclosed |
| CN-116283916-B | Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof | 中国科学院上海药物研究所 | 2024-06-11 | — | — | CN | disclosed |
| CN-118103369-A | Pyridolactam derivatives, preparation method and application thereof | 浙江海正药业股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024088351-A1 | COMPOUNDS AND USES THEREOF | SUZHOU ZANRONG PHARMA LIMITED (CN) | 2024-05-02 | — | — | WO | disclosed |
| EP-4182323-B1 | PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS | CHIESI FARM SPA (IT) | 2024-04-24 | — | — | EP | disclosed |
| CN-117903171-A | Integrin inhibitors of a class of bicyclic derivatives | 上海如凌生物医药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-4352055-A1 | O-LINKED THIADIAZOLYL COMPOUNDS AS DNA POLYMERASE THETA INHIBITORS | Ideaya Biosciences, Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| CN-113226310-B | 15-PGDH inhibitors | 杏林制药株式会社 | 2024-03-19 | — | — | CN | disclosed |
| EP-1713484-A2 | COMPOUNDS AND METHODS OF USE | AMGEN INC. (US) | 2006-10-25 | — | — | EP | disclosed |
| CN-1653054-A | Benzoxazine derivatives as 5-HT 6 modulators and uses thereof | HOFFMANN LA ROCHE (CH) | 2005-08-10 | — | — | CN | disclosed |
| WO-2005070891-A2 | COMPOUNDS AND METHODS OF USE | AMGEN INC (US) | 2005-08-04 | — | — | WO | disclosed |
| US-20040214999-A1 | Novel compounds for chemiluminescense procedures | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2004-10-28 | — | — | US | disclosed |
| WO-2004037829-A1 | NOVEL BENZOXAZOLE OR OXAZOLOPYRIDINE COMPOUNDS, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2004-05-06 | — | — | WO | disclosed |
| EP-1397678-A1 | LUCIFERIN HYDRAZIDES | Roche Diagnostics GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| EP-1397488-A1 | NOVEL COMPOUNDS FOR CHEMILUMINESCENSE PROCEDURES | Roche Diagnostics GmbH (DE) | 2004-03-17 | — | — | EP | disclosed |
| WO-2002099097-A1 | NOVEL COMPOUNDS FOR CHEMILUMINESCENSE PROCEDURES | ROCHE DIAGNOSTICS GMBH (DE) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002099428-A1 | LUCIFERIN HYDRAZIDES | ROCHE DIAGNOSTICS GMBH (DE) | 2002-12-12 | — | — | WO | disclosed |